Lancet Diabetes Endocrinol (2022) 10(5):35165
"What hasn't been even described or reported in the peer-reviewed medical literature is what does maintenance on these medications look like," Ashton said, adding, "That knowledge and awareness has to be there, that if you get to your goal weight, and you completely stop these medications, the vast majority, not all, but the vast majority of people will regain the weight that's lost." Ashton said patients on a medication like Wegovy should work closely with their doctor determine what is best in their individual situation
A KFF poll reveals that 1 in 8 adults (12%) say they're taking a GLP-1 drug, and more than 25% of users with health insurance are paying the full cost of the drugs themselves
The TRIUMPH-Outcomes cardiovascular and kidney trial is following adults living with obesity for several years to see whether retatrutide reduces serious heart and kidney complications, not just body weight
Notably, intravenous glutathione has a short plasma half-life, with most of the administered dose being cleared from circulation within minutes